Davita Healthcare (DVA) closed its recent trading session at $132.87, showing a +1.75% change from the previous day's closing price. The stock surpassed the S&P 500, with daily gains of 0.41%. Meanwhile, the Dow recorded a profit of 0.18%, while the technology-centric Nasdaq rose by 0.31%.
Today, shares in the kidney dialysis provider lost 5.2% in the past month. At the same time, the healthcare sector lost 0.38% and the S&P 500 won 3.15%.
Davita Healthcare's upcoming revenue releases will be of great interest to investors. The company is expected to post an EPS of $3.29, showing growth of 27.03% compared to last year's quarter. Meanwhile, Zacks Consensus estimates include net sales of $3.4 billion, up 4.27% from the same period last year.
Zacks Consensus estimates that earnings of $10.93 per share and revenues of $13.46 billion over the yearly period, showing a shift of +12.91% and +5.01% from last year, respectively.
Recent changes to Davita Healthcare analyst estimates also need to be eyeing investors. These revisions will help demonstrate the ever-changing nature of near business trends. Therefore, a positive change in estimates means analysts' optimism about business and profitability.
Based on our research, we believe that these estimated revisions are directly related to short-term stock movements. To make profits from now on, we have developed our own Zacks Rank, a model that provides a practical rating system, taking into account these estimate changes.
The Zacks Rank System ranges from #1 (Strong Buy) to #5 (Strong Cell), with an impressive track record of out-of-performance external audits, with #1 shares generating average annual returns since 1988. There has been no change in estimates for Zacks Consensus EPS over the past month. Davita Healthcare is currently in Zacks Rank #2 (Purchase).
Looking at the ratings, Davita Healthcare retains a forward P/E ratio of 11.95. This represents a discount compared to the industry's average forward P/E of 21.36.
Furthermore, we can observe that DVA currently boasts a PEG ratio of 0.94. This general metric is similar to the widely known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected revenue growth rate. When the market closed yesterday, the average PEG ratio for the healthcare-outpatient and home healthcare industry was 1.96.
Healthcare – The outpatient and home healthcare industries are part of the healthcare sector. Currently ranked 41 in the Zacks industry, the industry belongs to the top 17% tier of all 250+ industries.
